Adaptive Biotechnologies rises after quarterly sales beat
ReutersMay 2, 2025 4:13 PM
Medical device maker Adaptive Biotechnologies Corp's ADPT.O shares rise as much as 34.5% to over a year high of $9.9
Stock is set for its best day since its IPO in 2019, if gains hold
Late on Thursday, ADPT posted 25% rise in Q1 revenue to $52.44 million, beating analysts' estimates of $42.68 million
Co reported Q1 net loss of $29.8 million, compared to $47.5 million for the same period in 2024
Co reported cash, cash equivalents and marketable securities of $232.8 million as of March 31, 2025
Co expects full year total company cash burn to be between $50 million and $60 million, from the previous range between $60 million and $70 million
As of last close, ADPT has fallen 62.1% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
National Debt Bomb Ignited? Musk Warns U.S. Will Be 1000% Bankrupt Without AI
TradingKey - Tesla (TSLA) CEO Elon Musk recently issued another warning regarding the rapidly ballooning U.S. national debt. He stated clearly that without artificial intelligence and robotics, the United States will inevitably head toward fiscal bankruptcy.TradingKey
9 hours ago
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).TradingKey
9 hours ago
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.TradingKey
Fri, Feb 6
Is Bitcoin’s Four-Year Cycle Dead in 2026?
Is the Bitcoin 4-year cycle dead? After 2025 broke historical records with a red post-halving year, institutional analysts explore if the Bitcoin price has decoupled from the halving countdown. Analyze the impact of spot ETFs, global liquidity, and the roadmap to the 2028 halving in this 2026 marketTradingKey
Wed, Feb 4
